-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HF50731
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2484771-19-7.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 2484771-19-7 |
| Description | HF50731 (compound 21) is a potent CXCR4 antagonist. HF50731 shows strong CXCR4 binding affinity, with IC50 of 19.8 nM. |
Product Information
| Synonyms | HF50731|HY-146413|CS-0498742 |
| Molecular Weight | 414.682 |
| Molecular Formula | C26H46N4 |
| Canonical SMILES | C1CCC(CC1)NCCCNCC2=CC=C(C=C2)CNCCCNC3CCCCC3 |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 358 |
| Exact Mass | 414.37224748 |
| Target | CXCR; HIV |
| XLogP3-AA | 5.2 |
